Anzemet Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Anzemet: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_733.JPG
Anzemet 100mg Tab
Merrell Pharmaceuticals Inc
Pill Identification: ANZEMET  |  100
Drug Image file DrugItem_448.JPG
Anzemet 100mg Tab
Sanofi U.S. LLC
Pill Identification: ANZEMET  |  100
Drug Image file DrugItem_21701.JPG
Anzemet 100mg Tablet
Validus Pharmaceuticals LLC
Pill Identification: ANZEMET  |  100

What is this Medicine?

DOLASETRON (dol A se tron) is used to prevent nausea and vomiting caused by chemotherapy.

In-Depth Information
Select a Medication

Anzemet 100mg Tablet

NDC: 000881203
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Chemotherapy-induced Nausea/vomiting Prophylaxis

Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Anzemet 100mg Tablet
Drug Image file DrugItem_448.JPG
Sanofi U.S. LLC
Pill Identification: ANZEMET  |  100
Shape: oblong
Color: pink

Reported Side Effects for Anzemet 100mg Tablet

Hives Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Balance Problems Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Bundle-branch Block Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Blood In The Urine Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Inceased Urination Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Anaphylactoid Reactions Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Incoordination Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Breathing Difficulties Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<2.2%*
Severity: MILD
Onset: RAPID
Confusion Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Bruise Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Prolonged Bleeding Time Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Bruises Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Kidney Failure Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Shivering Incidence:
<2.2%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
<2.2%*
Severity: MODERATE
Onset: RAPID
ST-T Wave Changes Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Distressed Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Irregular Heart Beat Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Rate Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Constipation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Light Sensitivity Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Postural Low Blood Pressure Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<5.3%*
Severity: MODERATE
Onset: RAPID
Excessive Sweating Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.3-5.5%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.1-5.3%*
Severity: MILD
Onset: EARLY
Decreased Urination Incidence:
2.6%*
Severity: SEVERE
Onset: EARLY
Tired Incidence:
2.6-5.7%*
Severity: MILD
Onset: EARLY
Fever Incidence:
3.5%*
Severity: MILD
Onset: EARLY
Headache Incidence:
7.0-22.9%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Anzemet

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5